Loading clinical trials...
Loading clinical trials...
Prospective Phase II Study of Gemcitabine Plus Platinum Salt in Combination With Bevacizumab (Avastin®) for Metastatic Collecting Duct Carcinoma
Conditions
Interventions
Bevacizumab
Locations
19
France
Institut de Cancérologie de l'Ouest-Site Paul Papin
Angers, France
CHU Besançon
Besançon, France
Hôpital Saint André
Bordeaux, France
Centre François Baclesse
Caen, France
Hôpital Henri Mondor
Créteil, France
Centre Oscar Lambret
Lille, France
Start Date
December 1, 2014
Primary Completion Date
March 1, 2020
Completion Date
August 1, 2020
Last Updated
March 9, 2021
Lead Sponsor
UNICANCER
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions